Showing 16,641 - 16,660 results of 18,181 for search '(( significantly less decrease ) OR ( significantly ((a decrease) OR (linear decrease)) ))', query time: 0.48s Refine Results
  1. 16641
  2. 16642

    Data Sheet 1_Comparison between 75-g and 100-g oral glucose tolerance tests using international association of diabetes and pregnancy study group one-step diagnostic threshold to d... by Li-Li Zhou (1710085)

    Published 2025
    “…However, from fasting to 2h, the 100g group showed a steeper rise than the 75g group [Difference in slope (95% CI):0.412 (0.244 to 0.580), p<0.05], and a slower decline between 1-2h [Difference in slope (95% CI):0.047 (0.010 to 0.084), p<0.05].Glucose-adjusted continuous analysis showed that blood glucose levels were mostly associated with adverse outcomes, with the strength of association gradually decreasing from fasting to 1h and 2h. …”
  3. 16643

    Applications of Human Biostasis in Crewed Space Exploration by Josh Universe (21186797)

    Published 2025
    “…<p dir="ltr">Applications of Human Biostasis for Crewed Space Exploration is a presentation by Josh Universe, the Founder of the International Biohacking Community and Transhumanist Council, a science communicator, and a scientist-astronaut candidate. …”
  4. 16644

    Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  5. 16645

    Supplementary file 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  6. 16646

    Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  7. 16647

    Table 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  8. 16648

    Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  9. 16649

    Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  10. 16650

    Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …”
  11. 16651

    Table 2_Effects of supplementation with vitamin D3 on growth performance, lipid metabolism and cecal microbiota in broiler chickens.docx by Jiawei Li (559407)

    Published 2025
    “…Samples were collected after a 12-h fasted feeding on days 28, 56, and 84. Supplementary VD<sub>3</sub> significantly enhanced average daily gain (ADG) in broilers aged 57-84 d and 1-84 d, and increased leg muscle rate and fat content in breast and leg muscles and reduced abdominal fat rate of broilers at 84 d. …”
  12. 16652

    Table 1_Effects of supplementation with vitamin D3 on growth performance, lipid metabolism and cecal microbiota in broiler chickens.docx by Jiawei Li (559407)

    Published 2025
    “…Samples were collected after a 12-h fasted feeding on days 28, 56, and 84. Supplementary VD<sub>3</sub> significantly enhanced average daily gain (ADG) in broilers aged 57-84 d and 1-84 d, and increased leg muscle rate and fat content in breast and leg muscles and reduced abdominal fat rate of broilers at 84 d. …”
  13. 16653

    Table 3_Effects of supplementation with vitamin D3 on growth performance, lipid metabolism and cecal microbiota in broiler chickens.docx by Jiawei Li (559407)

    Published 2025
    “…Samples were collected after a 12-h fasted feeding on days 28, 56, and 84. Supplementary VD<sub>3</sub> significantly enhanced average daily gain (ADG) in broilers aged 57-84 d and 1-84 d, and increased leg muscle rate and fat content in breast and leg muscles and reduced abdominal fat rate of broilers at 84 d. …”
  14. 16654

    Full name and abbreviation. by Yuanqiang Lv (20623742)

    Published 2025
    “…</p><p>Results and conclusion</p><p>The results indicated that oxidative stress and immune response factor expressions quantity in Gallus gallus decreased significantly after 14 days of treatment, compared with model group, the low-dose treatment group’s SOD1, SOD3, GPX1, GPX2, GSR, H6DP, and HO-1 genes in liver were downregulated by 36.03%, 40.01%, 45.86%, 40.79%, 37.68%, 25.04%, and 29.89%, the IL-1, IL-2, IL-4, IL-6, IgA, IgM, and IgG genes in blood and spleen were downregulated by 26.59%, 34.19%, 21.19%, 28.18%, 35.93%, 12.67%, 21.81 and 35.93%, 22.85%, 21.19%, 28.78%, 35.93%, 15.36%, 29.73%. …”
  15. 16655

    Image 1_Effects of supplementation with vitamin D3 on growth performance, lipid metabolism and cecal microbiota in broiler chickens.pdf by Jiawei Li (559407)

    Published 2025
    “…Samples were collected after a 12-h fasted feeding on days 28, 56, and 84. Supplementary VD<sub>3</sub> significantly enhanced average daily gain (ADG) in broilers aged 57-84 d and 1-84 d, and increased leg muscle rate and fat content in breast and leg muscles and reduced abdominal fat rate of broilers at 84 d. …”
  16. 16656

    Table 4_Effects of supplementation with vitamin D3 on growth performance, lipid metabolism and cecal microbiota in broiler chickens.docx by Jiawei Li (559407)

    Published 2025
    “…Samples were collected after a 12-h fasted feeding on days 28, 56, and 84. Supplementary VD<sub>3</sub> significantly enhanced average daily gain (ADG) in broilers aged 57-84 d and 1-84 d, and increased leg muscle rate and fat content in breast and leg muscles and reduced abdominal fat rate of broilers at 84 d. …”
  17. 16657

    The animal experimental protocol. by Yuanqiang Lv (20623742)

    Published 2025
    “…</p><p>Results and conclusion</p><p>The results indicated that oxidative stress and immune response factor expressions quantity in Gallus gallus decreased significantly after 14 days of treatment, compared with model group, the low-dose treatment group’s SOD1, SOD3, GPX1, GPX2, GSR, H6DP, and HO-1 genes in liver were downregulated by 36.03%, 40.01%, 45.86%, 40.79%, 37.68%, 25.04%, and 29.89%, the IL-1, IL-2, IL-4, IL-6, IgA, IgM, and IgG genes in blood and spleen were downregulated by 26.59%, 34.19%, 21.19%, 28.18%, 35.93%, 12.67%, 21.81 and 35.93%, 22.85%, 21.19%, 28.78%, 35.93%, 15.36%, 29.73%. …”
  18. 16658

    Supplementary Material for: The impact of left ventricular structure and function on mortality in patients with aortic valve infective endocarditis treated with aortic valve replac... by figshare admin karger (2628495)

    Published 2025
    “…The mean LVEF was 54±11% preoperatively, decreasing to 51±11% postoperatively. The mean baseline LVEDd was 5.8±0.9 cm in males and 5.0±0.9 cm in females (p<0.001), decreasing to 5.2±0.9 cm in males and 4.7±0.6 cm in females after surgery (p=0.006). …”
  19. 16659

    Image 3_N1-methylnicotinamide promotes age-related cochlear damage via the overexpression of SIRT1.tif by Toru Miwa (8528715)

    Published 2025
    “…<p>Age-related hearing loss (ARHL) is a complex condition with genetic, aging, and environmental influences. …”
  20. 16660

    Table1_The long-term prognostic implications of free triiodothyronine to free thyroxine ratio in patients with obstructive sleep apnea and acute coronary syndrome.jpg by Yun Zhou (308977)

    Published 2024
    “…The FT3/FT4 ratio between OSA and non-OSA patients was not significantly different. During 2.8 (1.4, 3.5) years follow up, the risk of MACCE increased with the decreasing FT3/FT4 tertiles in patients with OSA (tertile3 as reference, tertile2: hazard ratio (HR) 1.26, 95% CI: 0.85-1.86, P = 0.255; tertile1: 1.60, 95% CI 1.11-2.32; P = 0.013). …”